Clinical Trial Update: A Single-center, Open-label, Single-dose Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Nalmefene 10 mg Tablets in Healthy Japanese Male Subjects [Phase 1]

View source ↗

Summary

A Phase 1 open-label single-dose study evaluated the safety, tolerability, and pharmacokinetic properties of nalmefene 10 mg in healthy Japanese male subjects; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence

Drugs mentioned

• Nalmefene (nalmefene)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Alcohol Dependence | Phase 1 | Status: COMPLETED | Results posted: 2017-04-18